Picture of Immuno-Biological Laboratories logo

4570 — Immuno-Biological Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapFalling Star

Table: Immuno Biological Lab -Q1 group results

Aug 7 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2020        Jun 30, 2019      Mar 31, 2021  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            116 mln             113 mln           549 mln    
                 (+2.9 pct)          (-34.0 pct)       (-4.8 pct)   
  Operating     loss 101 mln        loss 104 mln      loss 308 mln  
  Recurring     loss 127 mln        loss 127 mln      loss 410 mln  
  Net           loss 129 mln        loss 124 mln      loss 430 mln  
  EPS          loss 13.85 yen      loss 14.28 yen    loss 46.16 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T

Recent news on Immuno-Biological Laboratories

See all news